1. Home
  2. CDXS vs XFLT Comparison

CDXS vs XFLT Comparison

Compare CDXS & XFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.49

Market Cap

256.3M

Sector

Industrials

ML Signal

HOLD

Logo XAI Octagon Floating Rate & Alternative Income Term Trust of Beneficial Interest

XFLT

XAI Octagon Floating Rate & Alternative Income Term Trust of Beneficial Interest

HOLD

Current Price

$17.55

Market Cap

265.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDXS
XFLT
Founded
2002
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Investment Managers
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
256.3M
265.3M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CDXS
XFLT
Price
$1.49
$17.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
796.1K
89.1K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
14.17%
EPS Growth
43.82
N/A
EPS
N/A
N/A
Revenue
$138,590,000.00
N/A
Revenue This Year
$7.73
N/A
Revenue Next Year
$14.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
32.30
N/A
52 Week Low
$0.96
$3.02
52 Week High
$3.87
$19.48

Technical Indicators

Market Signals
Indicator
CDXS
XFLT
Relative Strength Index (RSI) 23.79 47.60
Support Level $1.10 $17.03
Resistance Level $1.86 $19.48
Average True Range (ATR) 0.15 0.29
MACD -0.07 0.01
Stochastic Oscillator 5.33 52.62

Price Performance

Historical Comparison
CDXS
XFLT

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

About XFLT XAI Octagon Floating Rate & Alternative Income Term Trust of Beneficial Interest

XAI Octagon Floating Rate & Alternative Income Trust is a diversified, closed-end management investment company which invests in a dynamically managed portfolio of floating-rate credit instruments and other structured credit investments within the private markets. The Trust's investment objective is to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle.

Share on Social Networks: